The White Rose Health Innovation Partnership (WRHIP) aims to accelerate new health-related technologies by facilitating interactions between academia, industry and the NHS using an open innovation approach. The new projects funded as part of this initiative are built upon a foundation of excellence in health innovation by the Partnership’s members. This series of Health Technology Bulletins offer an introduction to this research excellence and cover a broad range of clinical and technology areas.
Each bulletin is written to give a general introduction to the topic area along with short case studies of clinical applications of new knowledge. Information is also presented on where to learn more about these new technologies and health challenges, and how to access the network of health innovation professionals established by the Partnership.
'Our aim is to bring concepts
and ideas to life, dramatically
accelerating the rate at which
new and innovative technologies,
methodologies and practices reach
the medical and healthcare sectors'
and ideas to life, dramatically
accelerating the rate at which
new and innovative technologies,
methodologies and practices reach
the medical and healthcare sectors'
WRHIP Technology Bulletins
Annually 50% of people in the Western world die from cardiovascular diseases. Identifying areas of translational research that improve survival and rehabilitation by early detection, improving patient stratification and and monitoring treatment responses couldameliorate such human and financial burdens. Here we consider areas of clinical need and the challenges and opportunities that exist for cardiovascular research.
Urological problems are often a taboo subject for many as the symptoms associated with them can be highly embarrassing. It is estimated that as many as 80% of the population will suffer from some sort of urological problem during their lives.
Mental health problems are found in people of all ages, countries, regions and societies. In the age of digital communications, can technologies positively contribute towards a solution?
The traditional view of patients as passive recipients of new technologies or services is slowly changing. There is growing recognition of the value of incorporating the perspectives, experiences and wisdom of the individuals and communities served by the NHS, in the design, as well as the delivery and evaluation of healthcare.
Articular cartilage has a limited capacity for self-repair. Therefore, cartilage injuries caused through trauma, mechanical overloading due to joint misalignment or instability, may lead to significant cartilage defects/lesions which do not heal spontaneously and can result in a progressive erosion of the cartilage and development of osteoarthritis.
Drug delivery is the science of optimizing the administration a pharmaceutical or biopharmaceutical product. The aim is to maximize the therapeutic effect in the patient whilst minimizing the potential side effects of the intervention and increase patient compliance and satisfaction with the therapy.